Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study.
Schwenkglenks
Matthias
M
European Center of Pharmaceutical Medicine, University of Basel, Basel, Switzerland. m.schwenkglenks@unibas.ch
Pettengell
Ruth
R
Jackisch
Christian
C
Paridaens
Robert
R
Constenla
Manuel
M
Bosly
André
A
Szucs
Thomas D
TD
Leonard
Robert
R
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001835:Body Weight; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects / Q000379:methods; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D015994:Incidence; D016015:Logistic Models; D008875:Middle Aged; D015999:Multivariate Analysis; D020360:Neoadjuvant Therapy / Q000009:adverse effects / Q000379:methods; D009503:Neutropenia / Q000139:chemically induced* / Q000453:epidemiology / Q000209:etiology; D011446:Prospective Studies; D012307:Risk Factors
D000970:Antineoplastic Agents